Yasheen Zhou

发表

4-(Aminoalkylamino)-3-benzimidazole-quinolinones as potent CHK-1 inhibitors.

Z. Ni, D. Bussiere, S. Ramurthy, 2006, Bioorganic & medicinal chemistry letters.

Discovery of a Potent and Speci fi c M . tuberculosis Leucyl-tRNA Synthetase Inhibitor : ( S ) ‐ 3-( Aminomethyl )

David Barros, J. Plattner, Esther Pérez-Herrán, 2017 .

Discovery of a Potent and Specific M. tuberculosis Leucyl-tRNA Synthetase Inhibitor: (S)-3-(Aminomethyl)-4-chloro-7-(2-hydroxyethoxy)benzo[c][1,2]oxaborol-1(3H)-ol (GSK656).

David Barros, J. Plattner, Esther Pérez-Herrán, 2017, Journal of medicinal chemistry.

Second Pulse Current in Resistance Spot Welded TRIP Steel — Effects on the Microstructure and Mechanical Behavior The second pulse current improved mechanical properties when the fusion zone microstructure consisted of a recrystallized structure of martensite

Yasheen Zhou, V. Hernandez, Y. Okita, 2012 .

Synthesis and antibacterial evaluation of a novel tricyclic oxaborole-fused fluoroquinolone.

Hongwei Zhang, Yi Xia, J. Plattner, 2013, Bioorganic & medicinal chemistry letters.

Discovery of novel urea-based hepatitis C protease inhibitors with high potency against protease-inhibitor-resistant mutants.

R. Hamatake, Suoming Zhang, S. Baker, 2012, Journal of medicinal chemistry.

Benzoxaborole antimalarial agents. Part 2: Discovery of fluoro-substituted 7-(2-carboxyethyl)-1,3-dihydro-1-hydroxy-2,1-benzoxaboroles.

F. Gamo, Laura M Sanz, Huchen Zhou, 2012, Bioorganic & medicinal chemistry letters.

Synthesis and SAR of novel benzoxaboroles as a new class of β-lactamase inhibitors.

Yi Xia, S. Baker, M. Meewan, 2011, Bioorganic & medicinal chemistry letters.

Synthesis and structure-activity relationships of novel benzoxaboroles as a new class of antimalarial agents.

J. Gut, P. Rosenthal, F. Gamo, 2011, Bioorganic & medicinal chemistry letters.

Synthesis of new acylsulfamoyl benzoxaboroles as potent inhibitors of HCV NS3 protease.

Z. Ni, Suoming Zhang, S. Baker, 2010, Bioorganic & medicinal chemistry letters.

Synthesis and evaluation of novel alpha-amino cyclic boronates as inhibitors of HCV NS3 protease.

Z. Ni, P. Rowland, S. Baker, 2010, Bioorganic & medicinal chemistry letters.

Synthesis and biological evaluations of P4-benzoxaborole-substituted macrocyclic inhibitors of HCV NS3 protease.

Z. Ni, Suoming Zhang, S. Baker, 2010, Bioorganic & medicinal chemistry letters.

Discovery of novel P3-oxo inhibitor of hepatitis C virus NS3/4A serine protease.

R. Hamatake, Suoming Zhang, S. Baker, 2012, Bioorganic & medicinal chemistry letters.

Design, structure-activity relationship, and in vivo characterization of the development candidate NVP-HSP990.

Kristin M. Brinner, N. Pryer, T. Hendrickson, 2014, Journal of medicinal chemistry.

Discovery of 2-pyrimidyl-5-amidothiophenes as potent inhibitors for AKT: synthesis and SAR studies.

E. Fang, Sylvia Ma, J. Murray, 2006, Bioorganic & medicinal chemistry letters.

Design and synthesis of highly constrained factor Xa inhibitors: amidine-substituted bis(benzoyl)--diazepan-2-ones and bis(benzylidene)-bis(gem-dimethyl)cycloketones.

D. Case, A. Olson, Michael E. Johnson, 2003, Bioorganic & medicinal chemistry.

Inhibiting C-4 Methyl Sterol Oxidase with Novel Diazaborines to Target Fungal Plant Pathogens

L. Cowen, L. Whitesell, Gerard D. Wright, 2022, ACS chemical biology.

Chalcones and flavonoids as anti-tuberculosis agents.

Li-Ming Zhou, Li-Ming Zhou, Yuh-Meei Lin, 2002, Bioorganic & medicinal chemistry.

3-Benzimidazol-2-yl-1H-indazoles as potent c-ABL inhibitors.

C. Shafer, J. Jansen, Sylvia Ma, 2006, Bioorganic & medicinal chemistry letters.

Crystal Structure of a 1:1 Complex of Natural Diterpenoids: Absolute Configurations and Unambiguous NMR Spectral Assignments of Neoangustifolin and Epinodosinol

G. Cordell, Michael E. Johnson, Han-Dong Sun, 1997 .

Exploring Boron Applications in Modern Agriculture: A Structure-Activity Relationship Study of a Novel Series of Multi-Substitution Benzoxaboroles for Identification of Potential Fungicides.

L. Cowen, L. Whitesell, T. Pastoor, 2021, Bioorganic & medicinal chemistry letters.

Synthesis and SAR of acyclic HCV NS3 protease inhibitors with novel P4-benzoxaborole moieties.

Z. Ni, Suoming Zhang, S. Baker, 2011, Bioorganic & medicinal chemistry letters.

Linking Phenotype to Kinase: Identification of a Novel Benzoxaborole Hinge-Binding Motif for Kinase Inhibition and Development of High-Potency Rho Kinase Inhibitors

K. Jarnagin, F. Rock, Yong-Kang Zhang, 2013, The Journal of Pharmacology and Experimental Therapeutics.

Inhibiting Protein Prenylation with Benzoxaboroles to Target Fungal Plant Pathogens.

L. Cowen, L. Whitesell, Yong-Kang Zhang, 2020, ACS chemical biology.

Optimization of isoxazoline amide benzoxaboroles for identification of a development candidate as an oral long acting animal ectoparasiticide.

Zhixin Ge, J. Plattner, Yong-Kang Zhang, 2016, Bioorganic & medicinal chemistry letters.

Discovery of an orally bioavailable isoxazoline benzoxaborole (AN8030) as a long acting animal ectoparasiticide.

J. Plattner, Yong-Kang Zhang, T. Akama, 2015, Bioorganic & medicinal chemistry letters.

Amyloid fibril formation in microwell plates for screening of inhibitors

C. Cassidy, F. Stevens, R. Raffen, 2001, Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis.

A potent antimalarial benzoxaborole targets a Plasmodium falciparum cleavage and polyadenylation specificity factor homologue

Patrick G. Schupp, J. Derisi, J. Gut, 2017, Nature Communications.

Discovery of Novel Oral Protein Synthesis Inhibitors of Mycobacterium tuberculosis That Target Leucyl-tRNA Synthetase

Christopher B. Cooper, Lisa K. Woolhiser, J. Sacchettini, 2016, Antimicrobial Agents and Chemotherapy.

Discovery of a Novel Class of Boron-Based Antibacterials with Activity against Gram-Negative Bacteria

J. Nieman, S. Cusack, D. Livermore, 2013, Antimicrobial Agents and Chemotherapy.

Boron‐based phosphodiesterase inhibitors show novel binding of boron to PDE4 bimetal center

K. Jarnagin, J. Nieman, K. R. Maples, 2012, FEBS letters.

Comparative molecular modeling analysis of5‐amidinoindole and benzamidine binding to thrombin and trypsin: specific H‐bond formation contributes to high 5‐amidinoindole potency and selectivity for thrombin and factor Xa

Michael E. Johnson, Y Zhou, M E Johnson, 1999, Journal of molecular recognition : JMR.

Treatment of Skin Inflammation with Benzoxaborole Phosphodiesterase Inhibitors: Selectivity, Cellular Activity, and Effect on Cytokines Associated with Skin Inflammation and Skin Architecture Changes

K. Jarnagin, Olga Zemska, M. Meewan, 2016, The Journal of Pharmacology and Experimental Therapeutics.

Efficacy and Improved Resistance Potential of a Cofactor-Independent InhA Inhibitor of Mycobacterium tuberculosis in the C3HeB/FeJ Mouse Model

A. Korkegian, G. Robertson, T. Parish, 2019, Antimicrobial Agents and Chemotherapy.

Discovery of a cofactor-independent inhibitor of Mycobacterium tuberculosis InhA

A. Korkegian, T. Ioerger, P. Tonge, 2018, Life Science Alliance.

The 7-phenyl benzoxaborole series is active against Mycobacterium tuberculosis

A. Korkegian, J. Sacchettini, T. Ioerger, 2018, Tuberculosis.

Novel macrocyclic HCV NS3 protease inhibitors derived from α-amino cyclic boronates.

William McDowell, Yang Liu, Dazhong Fan, 2010, Bioorganic & medicinal chemistry letters.

Boron‐based phosphodiesterase inhibitors show novel binding of boron to PDE4 bimetal center

K. Jarnagin, J. Nieman, K. R. Maples, 2012, FEBS letters.

with Activity against Gram-negative Bacteria

J. Nieman, S. Cusack, D. Livermore, 2013 .